-
HEG1 (SKM9-2)
HEG1 (SKM9-2)
- 中文名称：
- HEG1 (SKM9-2)
- 英文名称：
- HEG1 (SKM9-2)
- 品牌：
- AAA Biotech
- 品牌介绍：
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具，核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号：
- AAA59372
- 规格：
- 5 Slides|3 mL (RTU)|0.1 mL (Concentrate)|7 mL (RTU)|0.5 mL (Concentrate)
- 保存建议：
- Store at 2-8°C (Control Slides: Store at 20-25°C)
- 货期：
- 6-8周
- 来源宿主：
- Mouse
- 反应种属：
- Human
- 应用：
- IHC (Immunohistochemistry)
- 免责声明：
- *本产品仅供科研实验使用，不得用于临床诊断。*
- 其他：
克隆性:Monoclonal
同型:IgG
克隆号:[SKM9-2]
特异性:N/A
纯度:N/A
形式：HEG1 is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH7.5, containing BSA and sodium azide as a preservative
浓度：N/A
- 说明书：
Intended Use: This antibody is intended for use in Immunohistochemical applications on formallin-fixed paraffin-embedded tissues (FFPE), frozen tissue sections, and cell preparations.
Sialylated protein HEG homolog 1 or Heart development protein with EGF like domains 1 (HEG1) is a novel calcium binding receptor protein involved in the Cerebral Cavernous Malformations (CCM) pathway and plays a regulatory role in heart and vessel formation by stabilizing endothelial cell junctions. HEG1 is a heavily glycosylated protein that participates in endothelial cell associations that develop the vascular system, and therefore plays a role in angiogenesis and the microenvironment of cellular adhesion.
The exact role of HEG1 in hepatocellular carcinoma is unclear, however, studies have shown HEG1 antibody expression indicates poor prognosis and plays important roles in hepatocellular carcinoma invasion, metastasis, and epithelial mesenchymal transition by activating Wnt/beta-catenin signaling. HEG1 mucin-like membrane protein has also been found to be a sensitive and specific biomarker for malignant mesothelioma in pleural (lung) and peritoneal (abdominal) membranes, and several other rare locations, where it supports the survival and proliferation of mesothelioma cells. HEG1 is potentially a useful prognostic biomarker and therapeutic target for malignant mesothelioma and hepatocellular, thyroid, and ovarian carcinomas.
HEG1 antibody has been found to be a highly specific and sensitive marker of epithelioid Malignant Mesothelioma and offers sensitivity comparable to conventional markers for Epithelioid Mesotheliomas, but provides considerably better specificity, such that the identification of epithelioid mesothelioma versus NSCLC and potentially could be confirmed with a combination of HEG1 antibody and a suitable broad spectrum carcinoma marker such as Claudin-4.
